Center for Klinisk Metabolisk Forskning

Medicin og biovidenskab

1. Type 2 Diabetes Mellitus 100%
2. Glucose 91%
3. Glucagon-Like Peptide-1 Receptor 67%
4. Placebos 50%
5. Type 1 Diabetes Mellitus 43%
6. Glucagon 42%
7. Glucagon-Like Peptide 1 37%
8. Liraglutide 37%
9. Peptides 36%
10. Insulin 33%
11. Hypoglycemia 32%
12. gastric inhibitory polypeptide receptor 31%
13. Cross-Over Studies 27%
14. Non-alcoholic Fatty Liver Disease 26%
15. Obesity 25%
16. semaglutide 25%
17. Meals 23%
18. Liver 23%
19. Incretins 22%
20. Bile Acids and Salts 22%
21. Hormones 19%
22. Randomized Controlled Trials 19%
23. Therapeutics 19%
24. Polypharmacy 18%
25. Islet Amyloid Polypeptide 17%
26. Body Weight 17%
27. Denmark 16%
28. Gastric Bypass 16%
29. Insulin Resistance 16%
30. Exenatide 15%
31. exendin (9-39) 14%
32. Fats 14%
33. Glucagon Receptors 14%
34. Hyperglycemia 14%
35. Glucagon-Like Peptide 2 13%
36. Bone and Bones 13%
37. Gallbladder 13%
38. Appetite 13%
39. Fasting 13%
40. Hydroxychloroquine 12%
41. Hepcidins 12%
42. Eating 12%
43. Hypoglycemic Agents 12%
44. Bone Resorption 12%
45. Overweight 11%
46. Azithromycin 11%
47. Fatty Liver 11%
48. Ghrelin Receptor 11%
49. Colesevelam Hydrochloride 11%
50. Gestational Diabetes 11%
51. Insulin Secretion 10%
52. Microbiota 10%
53. Homeostasis 10%
54. Safety 10%
55. Cohort Studies 10%
56. Glucose Tolerance Test 10%
57. Weight Loss 10%
58. Systematic Reviews 10%
59. fibroblast growth factor 21 9%
60. Hemoglobins 9%
61. Mortality 9%
62. Biomarkers 9%
63. Confidence Intervals 9%
64. Cardiovascular Diseases 9%
65. Cardiac Arrhythmias 9%
66. Fructosamine 9%
67. imeglimin 8%
68. Energy Metabolism 8%
69. Inflammation 8%
70. Tramadol 8%
71. Equivalence Trials 8%
72. Gastric Emptying 8%
73. Information Centers 8%
74. Renal Dialysis 8%
75. Observational Studies 8%
76. human MTMR9 protein 8%
77. Prediabetic State 8%
78. Pharmacology 8%
79. Medication Errors 8%
80. Clinical Trials 8%
81. Sitagliptin Phosphate 7%
82. Enteroendocrine Cells 7%
83. Adrenal Cortex Hormones 7%
84. Body Mass Index 7%
85. Energy Intake 7%
86. Cholecystokinin 7%
87. Outpatients 7%
88. C-Peptide 7%
89. Calcitonin 7%
90. Area Under Curve 7%
91. Obesity Management 7%
92. Controlled Clinical Trials 6%
93. Lipids 6%
94. Amino Acids 6%
95. Pancreatic Hormones 6%
96. Chronic Obstructive Pulmonary Disease 6%
97. Transcriptome 6%
98. Atopic Dermatitis 6%
99. Quality of Life 6%
100. Poisoning 6%